title: Should high mobility group box-1 protein (HMGB1) be measured in patients with severe sepsis and septic shock? If so, when, where, and how?
authors.forename: Mats
authors.initials: M
authors.lastname: Eriksson
mesh_terms: D000906:Antibodies / Q000627:therapeutic use; D015415:Biomarkers; D016207:Cytokines / Q000097:blood; D024243:HMGB1 Protein / Q000276:immunology / Q000378:metabolism*; D006305:Health Status Indicators; D006801:Humans; D018805:Sepsis / Q000276:immunology / Q000378:metabolism* / Q000401:mortality; D012772:Shock, Septic / Q000276:immunology / Q000378:metabolism* / Q000401:mortality; D013548:Sweden / Q000453:epidemiology
chemical_list: D000906:Antibodies; D015415:Biomarkers; D016207:Cytokines; D024243:HMGB1 Protein